1Lake JM,Wong RK.Review article:the management of achalasia-a comparison of different treatment modalities.Aliment Pharmacol Ther,2006,24:909-918.
2Leyden JE,Moss AC,MacMathuna P.Endoscopic pneumatic dilation versus botulinum toxin ection in the management of primary achalasia.Cochrane Database Syst Rev,2006:5046.
3Vittal H,Pasricha PF.Botulinum toxin for gastrointestinal disorders:therapy and mechanisms.Neurotox Res,2OO6,9:149-159.
6Pasricha PJ,Ravich WJ,Hendrix TR,et al.Intrasphincteric botulinum toxin for the treatment of achalasia.N Engl J Med,1999,332:774-778.
7Bonavina L,Incarbone R,Antoniazzi L,et al.Previous endoscopictreatment does not affect complication rate and outcome of laparoscopic heller myotomy and anterior fundoplication for oesophageal achalasia.Ital J Gastroenterol Hepatol,1999,31:827-830.
8Patti MG,Arcerito M,Pellegrini CA.Thoracoscopic and laparoscopic Heller's myotomy in the treatment of esophageal achalasia.Ann Chir Gynaecol,1995,84:159-164.
9Richter JE.Modern management of achalasia.Curr Treat Options Gastroentero1,2005,8:275-283.
10Anselmino M,Perdikis G,Hinder RA,et al.Heller myotomy is superior to dilatation for the treatment of early achalasia.Arch Surg,1997,132:233-240.
2Hulselmans M,Vanuytsel T,Degreef T,et al. Long-term outcome of pneumatic dilation in the treatment of achalasia[J]. Clin Gastroenterol Hepatol,2010,8:30-35.
